PULM Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2023Q3

FY2023Q4

1.86M

-0.53%

-1.050

-27.59%

1.77M

+3.69%

-1.040

-8.77%

Estimates Revision

Stock Price

Go Down

-14.54%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Pulmatrix Inc (PULM.O) is -0.88, compared to its 5-year average forward P/E of -1.18. For a more detailed relative valuation and DCF analysis to assess Pulmatrix Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-1.18

Current PE

-0.88

Overvalued PE

-0.28

Undervalued PE

-2.09

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

4.98

Current PS

0.00

Overvalued PS

11.26

Undervalued PS

-1.30

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

PULM News & Events

Events Timeline

No data

News

9.5

10-16PRnewswire

Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets

9.5

08-07NASDAQ.COM

Pulmatrix (PULM) Q2 Revenue Falls 100%

9.5

08-06PRnewswire

Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets

People Also Watch

Frequently Asked Questions

What is Pulmatrix Inc (PULM) stock price today?

The current price of PULM is 4.35 USD — it has decreased -5.02 % in the last trading day.

What is Pulmatrix Inc (PULM)'s business?

Pulmatrix, Inc. is a biopharmaceutical company. The Company is focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with unmet medical needs using its patented iSPERSE technology. The Company’s proprietary product pipeline includes treatments for central nervous system (CNS) disorders such as acute migraine and serious lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) and allergic bronchopulmonary aspergillosis (ABPA). Pulmatrix’s product candidates are based on its proprietary engineered dry powder delivery platform, iSPERSE, which seeks to enhance therapeutic delivery to the lungs by optimizing pharmacokinetics and reducing systemic side effects to improve patient outcomes. iSPERSE is a proprietary technology that allows a broad range of drugs to be formulated as small, dense, and dispersible particles for efficient drug delivery and deep penetration into the lungs.

What is the price predicton of PULM Stock?

Wall Street analysts forecast PULM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PULM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Pulmatrix Inc (PULM)'s revenue for the last quarter?

Pulmatrix Inc revenue for the last quarter amounts to 0.00 USD, decreased -100.00 % YoY.

What is Pulmatrix Inc (PULM)'s earnings per share (EPS) for the last quarter?

Pulmatrix Inc. EPS for the last quarter amounts to -0.24 USD, decreased -66.20 % YoY.

What changes have occurred in the market's expectations for Pulmatrix Inc (PULM)'s fundamentals?

The market is revising No Change the revenue expectations for PULM for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -14.54%.

How many employees does Pulmatrix Inc (PULM). have?

Pulmatrix Inc (PULM) has 2 emplpoyees as of December 16 2025.

What is Pulmatrix Inc (PULM) market cap?

Today PULM has the market capitalization of 15.89M USD.